Sign In
NewsRadar

Adaptimmune Ltd

Adaptimmune focuses on the use of T cell therapy to treat cancer and infectious disease. It aims to use the body’s own machinery – the T cell – to target and destroy cancerous or infected cells.

• Show past press releases
• Edit this company

Elevator Pitch
Adaptimmune focuses on the use of T cell therapy to treat cancer and infectious disease. It aims to use the body’s own machinery – the T cell – to target and destroy cancerous or infected cells.

Contact Information
Address:
 
 

Phone:
Fax:
Web:
Contact:
 
 
91 Park Drive
Milton Park
Abingdon OX14 4RY
United Kingdom
+44 (0) 1235 430000
+44 (0) 1235 430001
http://www.adaptimmune.com
James Noble
+44 (0) 1235 430000

Company Facts
Founded:Jul 2008
Founders:
CEO:James Noble
CTO or technical lead:
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:Early Stage
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


25,983
Tech investments
From our Online Data Service
16,806
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Aug 12€2.4MBusiness applications
Aug 12€0.7MMedical devices
Aug 12N/AMedical devices
Aug 9€7.0MSoftware development
Aug 9€0.3MeLearning
Aug 9N/AOther Biotechnology & Healthcare
Aug 7€3.8MDiagnostics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.